Immunophenotype of transitional metaplasia of the uterine cervix

International Journal of Gynecological Pathology

Volumn 18, Issue 2, 1999, Pages 125-129

  Harnden, Patricia ^a   Kennedy, Wendy ^a   Andrew, Alison C ^b   Southgate, Jennifer ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Asymmetric unit membrane; Cytokeratin; Metaplasia; Uterine cervix

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; PRIORITY JOURNAL; SQUAMOUS CELL METAPLASIA; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX EPITHELIUM;

EID: 0033039126     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199904000-00005     Document Type: Article

References (15)

1. Egan AJ, Russell P. Transitional (urothelial) cell metaplasia of the uterine cervix: morphological assessment of 31 cases. Int J Gynecol Pathol 1997;16:89-98.
2. Weir MM, Bell DA, Young RH. Transitional cell metaplasia of the uterine cervix and vagina: an underrecognized lesion that may be confused with high-grade dysplasia. A report of 59 cases. Am J Surg Pathol 1997;21:510-7.
3. Weir MM, Bell DA. Transitional cell metaplasia of the cervix: a newly described entity in cervicovaginal smears. Diagn Cytopathol 1998;18:222-6.
4. Miller N, Bedard YC, Cooter NB, Shaul DL. Histological changes in the genital tract in transsexual women following androgen therapy. Histopathology 1986;10:661-9.
5. Fetissof F, Dubois MP, Heitz PU, Lansac J, Arbeillebrassart B, Jobard P. Endocrine-cells in the female genital-tract. Int J Gynecol Pathol 1986;5:75-87.
6. Fetissof F, Arbeille B, Boivin F, Samgiao M, Henrion C, Lansac J. Endocrine-cells in ectocervical epithelium: an immunohistochemical and ultrastructural analysis. Virchows Archiv A Pathol Anat Histopathol 1987;411:293-8.
7. Moll R. Molecular diversity of cytokeratins: significance for cell and tumor differentiation. Acta Histochem Suppl 1991;41:117-27.
8. Moll R, Schiller DL, Franke WW. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol 1990;111: 567-80.
9. Moll R, Wu XR, Lin JH, Sun TT. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas. Am J Pathol 1995;147: 1383-97.
10. Moll R, Achtstatter T, Becht E, Balcarova-Ständer J, Ittensohn M, Franke WW. Cytokeratins in normal and malignant transitional epithelium: maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines. Am J Pathol 1988;132:123-44.
11. Booth C, Harnden P, Trejdosiewicz LK, Scriven S, Selby PJ, Southgate J. Stromal and vascular invasion in a human in vitro bladder cancer model. Lab Invest 1997;76:843-57.
12. Harnden P, Southgate J. Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas. J Clin Pathol 1997;50:1032-33.
13. Southgate J, Trejdosiewicz LK. Immunolabelling of cells and tissues: approaches and pitfalls. Hum Reprod 1997;12:65-75.
14. Southgate J, Hutton KA, Thomas DF, Trejdosiewicz LK. Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest 1994;71:583-94.
15. Scriven SD, Booth C, Thomas DF, Trejdosiewicz LK, Southgate J. Reconstitution of human urothelium from monolayer cultures. J Urol 1997;158:1147-52.